文献速递细菌感染、耐药与抗菌药物

抗菌药物耐药标志物数据库用于基因型预测耐药表型的大规模系统评估

Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: a systematic review.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该研究系统评估了公共抗菌药物耐药(AMR)标志物数据库 CARD 和 ResFinder 对临床分离株的耐药预测性能,使用来自 PATRIC 和 NDARO 的 2587 株五种临床相关病原体。CARD 和 ResFinder 的总体平衡准确度分别为 0.52(±0.12)和 0.66(±0.18),CARD 主要错误率更高(42.68% vs 25.06%),但极主要错误率更低(1.17% vs 4.42%)。结论指出数据库需进一步扩展、改进按抗生素而非按类别的标志物注释,并验证多变量标志物组合以达到临床效用。

要点

  • ResFinder 总体平衡准确度 0.66,高于 CARD 的 0.52。
  • CARD 主要错误率 42.68%,高于 ResFinder 的 25.06%。
  • CARD 极主要错误率 1.17%,低于 ResFinder 的 4.42%。

核心结论

  • AMR 数据库需进一步扩展、改进按抗生素的标志物注释并验证多变量标志物组合以达到临床效用。

研究设计与样本

  • 系统评估公共 AMR 标志物数据库 CARD 和 ResFinder 对临床分离株的耐药预测性能。
  • 最终数据集为来自 PATRIC 和 NDARO 的五种临床相关病原体共 2587 株分离株。

主要发现

  • CARD 和 ResFinder 的 WGS-AST 总体平衡准确度分别为 0.52(±0.12)和 0.66(±0.18)。
  • CARD 主要错误率为 42.68%,ResFinder 为 25.06%。
  • CARD 极主要错误率为 1.17%,ResFinder 为 4.42%。

临床怎么用

  • 临床采用 WGS-AST 时需注意所用 AMR 参考数据库的准确度与错误率差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance (AMR) is a rising health threat with 10 million annual casualties estimated by 2050. Appropriate treatment of infectious diseases with the right antibiotics reduces the spread of antibiotic resistance. Today, clinical practice relies on molecular and PCR techniques for pathogen identification and culture-based antibiotic susceptibility testing (AST). Recently, WGS has started to transform clinical microbiology, enabling prediction of resistance phenotypes from genotypes and allowing for more informed treatment decisions. WGS-based AST (WGS-AST) depends on the detection of AMR markers in sequenced isolates and therefore requires AMR reference databases. The completeness and quality of these databases are material to increase WGS-AST performance. METHODS: We present a systematic evaluation of the performance of publicly available AMR marker databases for resistance prediction on clinical isolates. We used the public databases CARD and ResFinder with a final dataset of 2587 isolates across five clinically relevant pathogens from PATRIC and NDARO, public repositories of antibiotic-resistant bacterial isolates. RESULTS: CARD and ResFinder WGS-AST performance had an overall balanced accuracy of 0.52 (±0.12) and 0.66 (±0.18), respectively. Major error rates were higher in CARD (42.68%) than ResFinder (25.06%). However, CARD showed almost no very major errors (1.17%) compared with ResFinder (4.42%). CONCLUSIONS: We show that AMR databases need further expansion, improved marker annotations per antibiotic rather than per antibiotic class and validated multivariate marker panels to achieve clinical utility, e.g. in order to meet performance requirements such as provided by the FDA for clinical microbiology diagnostic testing.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Mahfouz N, Ferreira I, Beisken S, et al. Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: a systematic review. J Antimicrob Chemother. 2020. PMID: 32658975. doi:10.1093/jac/dkaa257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。